Hyperice and UNINTERRUPTED Launch ‘Staying In Rhythm’ Content Series Featuring PGA TOUR Golfer Tony Finau, BMX Athlete Nigel Sylvester and MLB Shortstop Fernando Tatis Jr.

Premiering on September 20, 2021, Staying In Rhythm to Offer 3 Episodes Featuring PGA TOUR Golfer Tony Finau, BMX Athlete Nigel Sylvester & MLB Shortstop Fernando Tatis Jr. - All Hyperice Athlete Ambassadors

Hyperice, a global high-performance wellness brand specializing in percussion, dynamic air compression, vibration, thermal technology, mind technology, and contrast therapy, today announced a new partnership with UNINTERRUPTED, the Sports Emmy award winning athlete empowerment brand part of the media conglomerate built by NBA superstar LeBron James and his longtime business partner Maverick Carter, to launch an exclusive new content series: Staying In Rhythm.

Premiering on September 20, 2021, Staying In Rhythm will offer three episodes featuring PGA TOUR golfer Tony Finau, BMX athlete Nigel Sylvester and MLB shortstop Fernando Tatis Jr. – all Hyperice athlete ambassadors. Each episode will tell a multi-dimensional story about how each athlete uses their passions to help fuel their success both in and around competition. Starting with Finau, ahead of the start of the Ryder Cup on September 24, the episodes will launch on both Hyperice and UNINTERRUPTED channels, with the remaining episodes featuring Sylvester and Tatis Jr. to premiere later this year.

“Athletes are often perceived as being somewhat one-dimensional,” said Tony Finau, PGA TOUR golfer. “But, I’m also a dad, a husband, an avid sports fan, a lover of food and music; as well as many other things. It’s the combination of these things that drives me to get the most out of every day.”

The series was created as a result of a mutual partnership between UNINTERRUPTED and Hyperice – both brands have a passion for telling authentic stories that highlight athletes. The new collaboration comes on the heels of Hyperice’s recent announcement about its evolution to a holistic high-performance wellness brand. The new, modern approach allows Hyperice to reimagine its brand identity to better serve a broader audience of athletes and help people everywhere do the things they love, and do it more.

“Our collaboration with UNINTERRUPTED marks another pivotal moment in our evolution to a high-performance wellness brand by showing these elite athletes as both the superheroes and the real people they are,” said Andrew Samson, VP of Marketing at Hyperice. “Our ambition with this series is to highlight these iconic athletes by telling their personal stories on how they compete and stay at the top of their game and also find joy in other dimensions of their lives as well.”

The series will live on UNINTERRUPTED, in addition to UNINTERRUPTED YouTube, Instagram, Facebook and Twitter and will also be available on Hyperice’s Instagram and YouTube channels. 

SourceHyperice

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”